Latest Interviews
Showing 1–5 of 5 transcripts.
Clear all filters- Milken Institute32 min
Conversation with Senator Joe Manchin, Jigar Shah, & Chevron CEO Michael Wirth | Global Conference
Joe Manchin, Jigar Shah, Michael Wirth, David Westin, Mike
Debate leaders, including Senator Manchin and LPO Director Jigar Shah, examined the $500 billion federal energy investment framework while clashing over the pace of EV subsidies, hydrogen regulation, and the necessity of government loans to de-risk private capital. Key figures emphasized that despite rapid solar deployment, permitting bottlenecks and conflicting agency signals threaten grid stability and the timely retirement of fossil assets. The discussion concluded by highlighting the urgent need for comprehensive permitting reform to align domestic economic incentives with global net-zero trajectories before the current funding authority expires.
- Milken Institute34 min
A Conversation with PepsiCo CEO Indra Nooyi
Indra Nooyi, Michael Milken, Andrew, Mike
PepsiCo CEO Indra Nooyi transformed the beverage and snack giant through "Performance with Purpose," a strategy that integrated social and environmental sustainability into core operations while shifting the revenue portfolio toward healthier product lines. This cultural overhaul was driven by scientific leadership under Chief Scientific Officer Dr. Mahmood Khan and reinforced by tying executive compensation to specific nutritional and environmental goals. Nooyi further extended the company's impact by forging partnerships with healthcare institutions to improve access for underserved veterans and advocating for systemic policy changes to address chronic disease and nutritional equity.
- Milken Institute1h 0m
Health Care in the Digital Age
Anna, Mike, Patrick, Atul, Victor, John
A strategic partnership between BlackBerry and a biotech firm is addressing the critical security and infrastructure gaps in healthcare by developing a portable "passport" device for full human genome storage and a secure "mission control" center. This initiative supports a broader paradigm shift from organ-based medicine to molecular-level treatments, leveraging dynamic data and technologies like engineered natural killer cells to extend survival in aggressive cancers. Despite these advancements, the industry faces significant hurdles including a lack of interoperability, stringent FDA approval delays for biomarkers, and the need to bridge the digital divide for equitable patient empowerment.
- Milken Institute54 min
The 2014 Atlanta Summit - - Lunch Program
Judith, Trevor, Mike, Carmen, Frida, Tom
This event examines the century-long strategic evolution of major philanthropies like the Rockefeller Foundation, detailing their pivot from medical cures to integrated public health systems and the resulting cross-disciplinary fields. It highlights modern innovations such as geospatial data integration for polio eradication and the rise of non-traditional partnerships between governments, pharmaceutical giants like Pfizer, and patient advocacy groups to address both infectious and non-communicable diseases. The discussion further underscores global health security challenges, including antimicrobial resistance and pandemic preparedness, while showcasing how mobile technology and crowdsourcing enable developing nations to leapfrog infrastructure barriers.
- Milken Institute1h 1m
Global Models for Financing America's Infrastructure
Dale, Stephen Goldsmith, Sam Barron, William Reed, Sarah Clark, Sean Glodek, Mike, Lawrence Gottlieb
A global infrastructure summit highlights a critical $3 trillion U.S. investment gap and the urgent need to shift from public financing to private capital models like Public-Private Partnerships to meet rising demand. Experts contrast the U.S. lag in social infrastructure financing against international success stories from Canada and Russia, emphasizing how structural tax barriers currently prevent institutional investors from accessing stable, long-term yield opportunities. With 41 new projects in the pipeline and emerging legislative pushes to expand tax-exempt tools, the panel anticipates a surge in availability-payment deals that transfer construction risk to the private sector while addressing a significant mismatch between public financing costs and investor return expectations.